Control of tumor growth and metastasis with prostacyclin and thromboxane synthetase inhibitors: evidence for a new antitumor and antimetastatic agent (BAY g 6575)

Prog Clin Biol Res. 1982:89:295-331.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antineoplastic Agents*
  • Arachidonic Acids / therapeutic use
  • Cell Line
  • DNA Replication / drug effects
  • Epoprostenol / therapeutic use
  • Fibrinolytic Agents / therapeutic use*
  • Leukotrienes*
  • Lipid Peroxides*
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / secondary
  • Male
  • Melanoma / drug therapy*
  • Mice
  • Mice, Inbred C57BL
  • Neoplasm Metastasis / physiopathology*
  • Neoplasms, Experimental / drug therapy
  • Neoplasms, Experimental / physiopathology
  • Oxidoreductases / antagonists & inhibitors*
  • Peroxides / therapeutic use
  • Pyrazoles / therapeutic use*
  • Pyrazolones*
  • Thromboxane-A Synthase / antagonists & inhibitors*

Substances

  • Antineoplastic Agents
  • Arachidonic Acids
  • Fibrinolytic Agents
  • Leukotrienes
  • Lipid Peroxides
  • Peroxides
  • Pyrazoles
  • Pyrazolones
  • 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid
  • Epoprostenol
  • Oxidoreductases
  • Thromboxane-A Synthase
  • nafazatrom